.

Deeper Knowledge, Faster

  • Anticipate your formulary budget
  • Analyze global market entry opportunities
  • Identify first generic entrants

► See Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

AstraZeneca
Medtronic
Julphar
Covington
Argus Health
Boehringer Ingelheim
Cipla
Deloitte
Baxter
Farmers Insurance

Generated: June 24, 2017

DrugPatentWatch Database Preview

NISOLDIPINE Drug Profile

« Back to Dashboard

Which patents cover Nisoldipine, and when can generic versions of Nisoldipine launch?

Nisoldipine is a drug marketed by Mylan and is included in two NDAs.

The generic ingredient in NISOLDIPINE is nisoldipine. There are eight drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the nisoldipine profile page.

Summary for Tradename: NISOLDIPINE

Patents:0
Applicants:1
NDAs:2
Suppliers / Packagers: see list2
Bulk Api Vendors: see list59
Clinical Trials: see list4
Patent Applications: see list3,569
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:NISOLDIPINE at DailyMed

Pharmacology for Tradename: NISOLDIPINE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mylan
NISOLDIPINE
nisoldipine
TABLET, EXTENDED RELEASE;ORAL091001-001Jan 26, 2011ABRXNoNo► Subscribe► Subscribe
Mylan
NISOLDIPINE
nisoldipine
TABLET, EXTENDED RELEASE;ORAL079051-003Jul 25, 2008RXNoYes► Subscribe► Subscribe
Mylan
NISOLDIPINE
nisoldipine
TABLET, EXTENDED RELEASE;ORAL091001-004Jan 26, 2011ABRXNoNo► Subscribe► Subscribe
Mylan
NISOLDIPINE
nisoldipine
TABLET, EXTENDED RELEASE;ORAL091001-002Jan 26, 2011ABRXNoNo► Subscribe► Subscribe
Mylan
NISOLDIPINE
nisoldipine
TABLET, EXTENDED RELEASE;ORAL091001-003Jan 26, 2011RXNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Covington
Deloitte
US Army
Federal Trade Commission
AstraZeneca
McKinsey
Colorcon
Teva
Cerilliant
Fuji

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot